Literature DB >> 26658839

In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.

M Martínez-Moreno1, M Leiva2, N Aguilera-Montilla1, S Sevilla-Movilla1, S Isern de Val1, N Arellano-Sánchez1, N C Gutiérrez3, R Maldonado4, J Martínez-López4, I Buño5, J A García-Marco6, P Sánchez-Mateos7, A Hidalgo2,8, A García-Pardo1, J Teixidó1.   

Abstract

Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) cells must attach to the bone marrow (BM) microvasculature before lodging in the BM microenvironment. Using intravital microscopy (IVM) of the BM calvariae we demonstrate that the α4β1 integrin is required for MM and CLL cell firm arrest onto the BM microvasculature, while endothelial P-selectin and E-selectin mediate cell rolling. Talin, kindlin-3 and ICAP-1 are β1-integrin-binding partners that regulate β1-mediated cell adhesion. We show that talin and kindlin-3 cooperatively stimulate high affinity and strength of α4β1-dependent MM and CLL cell attachment, whereas ICAP-1 negatively regulates this adhesion. A functional connection between talin/kindlin-3 and Rac1 was found to be required for MM cell attachment mediated by α4β1. Importantly, IVM analyses with talin- and kindlin-3-silenced MM cells indicate that these proteins are needed for cell arrest on the BM microvasculature. Instead, MM cell arrest is repressed by ICAP-1. Moreover, MM cells silenced for talin and kindlin-3, and cultured on α4β1 ligands showed higher susceptibility to bortezomib-mediated cell apoptosis. Our results highlight the requirement of α4β1 and selectins for the in vivo attachment of MM and CLL cells to the BM microvasculature, and indicate that talin, kindlin-3 and ICAP-1 differentially control physiological adhesion by regulating α4β1 activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26658839     DOI: 10.1038/leu.2015.332

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  57 in total

1.  MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.

Authors:  A Stacchini; M Aragno; A Vallario; A Alfarano; P Circosta; D Gottardi; A Faldella; G Rege-Cambrin; U Thunberg; K Nilsson; F Caligaris-Cappio
Journal:  Leuk Res       Date:  1999-02       Impact factor: 3.156

Review 2.  The tail of integrins, talin, and kindlins.

Authors:  Markus Moser; Kyle R Legate; Roy Zent; Reinhard Fässler
Journal:  Science       Date:  2009-05-15       Impact factor: 47.728

3.  Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.

Authors:  Tanja Nicole Hartmann; Valentin Grabovsky; Wei Wang; Petra Desch; Gabriele Rubenzer; Stefan Wollner; Inbal Binsky; Alexandra Vallon-Eberhard; Anita Sapoznikov; Meike Burger; Idit Shachar; Michal Haran; Marek Honczarenko; Richard Greil; Ronen Alon
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

4.  Rap1 controls lymphocyte adhesion cascade and interstitial migration within lymph nodes in RAPL-dependent and -independent manners.

Authors:  Yukihiko Ebisuno; Koko Katagiri; Tomoya Katakai; Yoshihiro Ueda; Tomomi Nemoto; Hiroyuki Inada; Junichi Nabekura; Takaharu Okada; Reiji Kannagi; Toshiyuki Tanaka; Masayuki Miyasaka; Nancy Hogg; Tatsuo Kinashi
Journal:  Blood       Date:  2009-11-25       Impact factor: 22.113

Review 5.  Pathogenesis of myeloma.

Authors:  Kenneth C Anderson; Ruben D Carrasco
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.

Authors:  David García-Bernal; Javier Redondo-Muñoz; Ana Dios-Esponera; Raphaël Chèvre; Elvira Bailón; Mercedes Garayoa; Nohemí Arellano-Sánchez; Norma C Gutierrez; Andrés Hidalgo; Angeles García-Pardo; Joaquin Teixidó
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 7.  The genetic architecture of multiple myeloma.

Authors:  Gareth J Morgan; Brian A Walker; Faith E Davies
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

Review 8.  Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies.

Authors:  Elisa ten Hacken; Jan A Burger
Journal:  Pharmacol Ther       Date:  2014-07-19       Impact factor: 12.310

9.  Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally.

Authors:  Andrés Hidalgo; Linnea A Weiss; Paul S Frenette
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

10.  The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading.

Authors:  Simona Degani; Fiorella Balzac; Mara Brancaccio; Simona Guazzone; Saverio Francesco Retta; Lorenzo Silengo; Alessandra Eva; Guido Tarone
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

View more
  18 in total

1.  α4β1 integrin associates with VEGFR2 in CLL cells and contributes to VEGF binding and intracellular signaling.

Authors:  Alejandra Gutiérrez-González; Noemí Aguilera-Montilla; Estefanía Ugarte-Berzal; Elvira Bailón; Isabel Cerro-Pardo; Clara Sánchez-Maroto; Lara García-Campillo; José A García-Marco; Angeles García-Pardo
Journal:  Blood Adv       Date:  2019-07-23

Review 2.  Role of LFA-1 and ICAM-1 in Cancer.

Authors:  Manuel Reina; Enric Espel
Journal:  Cancers (Basel)       Date:  2017-11-03       Impact factor: 6.639

Review 3.  Inside the Cell: Integrins as New Governors of Nuclear Alterations?

Authors:  Elena Madrazo; Andrea Cordero Conde; Javier Redondo-Muñoz
Journal:  Cancers (Basel)       Date:  2017-07-06       Impact factor: 6.639

Review 4.  Molecular Players in Hematologic Tumor Cell Trafficking.

Authors:  Javier Redondo-Muñoz; Angeles García-Pardo; Joaquin Teixidó
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

Review 5.  Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment.

Authors:  Alessandro Natoni; Raghvendra Bohara; Abhay Pandit; Michael O'Dwyer
Journal:  Front Bioeng Biotechnol       Date:  2019-10-04

6.  Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model.

Authors:  Alessandro Natoni; Mariah L Farrell; Sophie Harris; Carolyne Falank; Lucy Kirkham-McCarthy; Matthew S Macauley; Michaela R Reagan; Michael O'Dwyer
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

7.  Editorial: Leukocyte Trafficking in Homeostasis and Disease.

Authors:  Joaquin Teixidó; Andres Hidalgo; Susanna Fagerholm
Journal:  Front Immunol       Date:  2019-11-01       Impact factor: 7.561

8.  E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.

Authors:  A Natoni; T A G Smith; N Keane; C McEllistrim; C Connolly; A Jha; M Andrulis; E Ellert; M S Raab; S V Glavey; L Kirkham-McCarthy; S K Kumar; S C Locatelli-Hoops; I Oliva; W E Fogler; J L Magnani; M E O'Dwyer
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528

9.  EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.

Authors:  Miguel A Flores; Paula Fortea; Eva M Trinidad; Dolores García; Gloria Soler; Francisco J Ortuño; Agustín G Zapata; Luis M Alonso-Colmenar
Journal:  Oncotarget       Date:  2016-07-26

Review 10.  VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical Aspects.

Authors:  Andrea Härzschel; Antonella Zucchetto; Valter Gattei; Tanja Nicole Hartmann
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.